Clinical Trial

Efficacy and Safety of HUC3-637 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
A multicenter, randomized, single-blind, active controlled, phase III clinical trial to evaluate the efficacy and safety of HUC3-637 in patients with primary open angle glaucoma or ocular hypertension
Trial Details
NCT Number NCT07335211
Lead Sponsor Huons Co., Ltd.
Conditions Primary Open Angle Glaucoma (POAG), Ocular Hypertension
Enrollment 206 participants
Start Date 2026-01
Primary Completion 2027-11 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-01-13